Position
Fidelity in Arcus Biosciences, Inc.
Back to the book · All holders of RCUS
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $10.8M$21.60 → $30.83
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.14M | $27.1M | — | — | — | 0.0% |
| Q1 2026 | 1.17M | $25.2M | $21.60 | −$2.53M | $649.6K | 0.0% |
| Q2 2026 | 4.05M | $124.9M | $30.83 | $10.8M | $88.9M | 0.0% |